GENETICS Gene Therapy Might Have Its First Blockbuster Antonio Regalado | MIT Technology Review “…drug giant Novartis expects to win approval to launch what it says will be the first ‘blockbuster’ gene-replacement treatment. A blockbuster is any drug with more than $1 billion in sales each year. The treatment, called Zolgensma, is able to save […]
This Week's Awesome Stories From Around the Web (Through May 25)
Singularity Hub - 25 May 2019 16:00
GENETICS Gene Therapy Might Have Its First Blockbuster Antonio Regalado | MIT Technology Review “…drug giant Novartis expects to win approval to launch what it says will be the first ‘blockbuster’ gene-replacement treatment. A blockbuster is any drug with more than $1 billion in sales each year. The treatment, called Zolgensma, is able to save […]
Share this Article
Recommended